久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Chinese scholars publish biologics guideline in international journal

By Chen Meiling | chinadaily.com.cn | Updated: 2025-05-07 20:26
Share
Share - WeChat

A Chinese guideline on the use of biologic agents in treating chronic rhinosinusitis with nasal polyps was recently published in the 2025 China Issue of Allergy, one of the most prestigious journals in the global fields of allergology and clinical immunology.

It focuses on China-specific clinical data, systematically standardizing key aspects of biologic treatment, such as patient selection, therapeutic protocols and efficacy evaluation, providing authoritative guidance for clinical practice.

"Emerging biologics that selectively target key cytokines present a promising therapeutic alternative for patients suffering from severe, uncontrollable chronic rhinosinusitis with nasal polyps," according to the guideline.

It's the first time that Chinese scholars have published a guideline-type document in a top-tier international journal in this field, offering valuable Chinese experience for global biologic applications, said Zhang Luo, president of Beijing Tongren Hospital and guest editor of the issue, at a news conference in Beijing on Wednesday.

"In the last two decades, the problems of allergic diseases have been increasing dramatically in the world. Now we are facing 2 billion patients with allergic diseases, so this is a serious threat to humankind in the future," he said.

"In the past, we primarily relied on nasal corticosteroid sprays and oral antihistamines, both of which are chemical-based medications. These treatments have been widely used and can effectively control symptoms. However, since they require frequent administration (often daily), patients may find them inconvenient. Now, with these new biologics, just about three injections over an allergy season can effectively manage symptoms. In terms of both efficacy and duration of effect, they represent an improvement over traditional treatments," Zhang said.

He said these medicines are now available in major hospitals, such as in his hospital. However, since biologics are relatively new, their cost remains high — for example, a single injection may cost around 1,000 to 2,000 yuan ($138-276). "But as their use becomes more widespread, prices are expected to gradually decrease, making them more accessible to a larger number of patients," he added.

The 2025 China Issue of Allergy includes 32 articles focusing on the latest research progress of Chinese scholars in areas such as the link between environmental pollution and asthma pathogenesis, gut microbiota dysbiosis and allergies, as well as the mechanisms underlying drug hypersensitivity.

Cezmi Akdis, editor-in-chief of the journal Allergy, the official journal of the European Academy of Allergy and Clinical Immunology, praised China's contribution to the study of allergy, which has "immensely increased" in the last two decades.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 亚洲在线观看免费 | 国产精品久久久久久久久岛 | 高清在线精品一区二区 | 国产a级三级三级三级 | 国产成人在线免费观看 | 欧美国产日韩在线 | 国产精品久久久久无毒 | 亚洲一区 欧美 | 亚洲更新| 欧美一级三级 | 一二三区在线观看 | 亚洲欧美另类专区 | 91看片淫黄大片欧美看国产片 | 亚洲成a人在线播放www | 一级毛片免费在线 | 久久国产成人精品麻豆 | 超清国产粉嫩456在线免播放 | 亚洲精品视频专区 | 99热久久国产综合精品久久国产 | 亚洲国产日韩在线 | 精品亚洲成a人在线观看 | 欧美在线观看不卡 | 国产成人久久综合二区 | 欧美三级三级三级爽爽爽 | 亚洲欧美日本韩国综合在线观看 | 亚洲精品在线免费 | 免费一级毛片麻豆精品 | 男女晚上爱爱的视频在线观看 | 成人免费视频69 | 亚洲黄区 | 美女个护士一级毛片亚洲 | 精品欧美一区二区精品久久 | 日本高清视频www夜色资源 | 欧美一级纶理片免费 | 亚洲天堂免费看 | 一区二区成人国产精品 | 国产亚洲精品久久久久久无 | 国产一级视频在线观看 | 特级片视频 | 国产成人a一区二区 | 日韩精品在线免费观看 |